pentetic acid has been researched along with Creutzfeldt-Jakob Syndrome in 2 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Creutzfeldt-Jakob Syndrome: A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27))
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liou, HH | 1 |
| Chiu, HC | 1 |
| Liu, HM | 1 |
| Perkins, AC | 1 |
| Frier, M | 1 |
2 other studies available for pentetic acid and Creutzfeldt-Jakob Syndrome
| Article | Year |
|---|---|
Abnormal enhancement of the left putamen on brain MRI in a case of proven Creutzfeldt-Jakob disease.
Topics: Biopsy; Contrast Media; Creutzfeldt-Jakob Syndrome; Diagnosis, Differential; Dominance, Cerebral; Fr | 1996 |
Bad blood and biologicals: the need for new radiopharmaceutical source materials.
Topics: Biological Products; Blood; Chemistry, Pharmaceutical; Creutzfeldt-Jakob Syndrome; Drug Contaminatio | 1999 |